Medical scientist Botond Roska has landed a €1 million check from Germany’s Körber Foundation for his groundbreaking research. His gene-based treatment to restore sight has already entered clinical trials. Botond Roska, who works in the Swiss city of Basel, has uncovered a gene-based therapy that reprograms cells in the human eye so that they can perform the work of the light-sensitive receptors needed for human vision, according to the Körber Foundation that hands out the annual prize. It is hoped the procedure will reactivate the retinas of the blind.
The medical scientist said that, for the time being, the process creates a level of vision similar to watching television in black and white. Clinical tests on blind volunteers are already underway as a result of the Budapest-born researcher’s groundbreaking work. “Roska’s research has woken up hope that new treatment methods might restore the ability to see in the blind,” said Hamburg Mayor Peter Tschentscher at the ceremony on Monday. The Körber Foundation’s prize was first awarded in 1985, and it recognizes scientists whose work has applied futuristic techniques to physical sciences.
The son of a computer scientist and a pianist, Roska began his career in medicine “after a detour,” said Tschentscher. The scientist first studied the cello at the Liszt Ferenc Academy of Music in Budapest, but had to give up the instrument following an injury. He then began to pursue medicine and mathematics. Last year’s winner of the prestigious prize was German artificial intelligence scientist Bernhard Schölkopf of the Max Planck Society.
Source: DW
Global site 
Finnish site